Showing results (131-140 of 414) with videos related to
Sort By:
Pageof 42
International Journal of Clinical Practice|June 16, 2001
Risedronate: clinical usageR D Chapurlat, P D DelmasBailliere'S Clinical Rheumatology|August 1, 1997
Osteoporosis: outstanding issuesP D Delmas, A D WoolfLa Revue De Medecine Interne|November 1, 1984
[Diphosphonates in the treatment of hypercalcemia]P D Delmas, P J MeunierThe Journal of Clinical Endocrinology and Metabolism|March 1, 1992
Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemiaJ J Body, P D DelmasAnnals of the Rheumatic Diseases|July 16, 2002
Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activationG Chevrel, P Garnero, P MiossecJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 19, 2004
Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analysesP D Delmas, Zhengqing Li, Cyrus CooperJournal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1987
Radioimmunoassay for osteonectin. Concentrations in bone, nonmineralized tissues, and bloodL Malaval, B Fournier, P D DelmasClinica Chimica Acta; International Journal of Clinical Chemistry|June 30, 1989
Evidence that free gamma carboxyglutamic acid circulates in serumB Fournier, E Gineyts, P D DelmasActa Endocrinologica|September 1, 1988
Specific radioimmunoassay for ovine bone gla-protein (osteocalcin)P Pastoureau, B Merle, P D DelmasClinical and Experimental Rheumatology|February 19, 2004
Biochemical markers of joint tissue turnover in early rheumatoid arthritisP Garnero, P Geusens, R LandewéPageof 42